Nanochon Performs First Case in the Chondrograft™ First-in-Human Clinical Study
WASHINGTON — Nanochon, a medical device company developing Chondrograft™, a novel 3D-printed patented implant for the treatment of articular cartilage defects of the knee, today announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study. The study is designed to evaluate the safety and performance of Chondrograft™ in patients with focal […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
